FRBZ1 Activators
FRBZ1 activators belong to a distinct class of chemical compounds that have garnered interest within the field of molecular biology and genetics. These compounds are specifically designed to modulate the activity of FRBZ1, a protein-coding gene that plays intricate roles in various cellular processes. FRBZ1, which stands for Ferroptosis Resistance Protein BZ1, is a relatively less characterized gene with limited available information regarding its functions. FRBZ1 activators function by targeting specific regulatory elements within the FRBZ1 gene, often situated in promoter or enhancer regions, with the primary goal of enhancing its transcription and subsequent translation into functional protein products.
The precise mechanisms through which FRBZ1 activators exert their effects may vary, but their fundamental purpose is to serve as molecular switches, amplifying the activity of FRBZ1. Researchers are continually exploring the potential applications and implications of FRBZ1 activation, aiming to deepen our understanding of how this gene contributes to cellular processes. This class of compounds holds promise for advancing our knowledge of gene regulation, particularly within the context of less-studied genes like FRBZ1, offering opportunities to uncover the intricate mechanisms that may govern its role in various biological contexts. FRBZ1 activators represent valuable tools in the ongoing exploration of molecular biology, providing avenues to decipher the complex roles that FRBZ1 may play in cellular functions and its potential involvement in ferroptosis resistance and related processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $117.00 $344.00 | 3 | |
Betulinic acid can influence various signaling pathways, potentially leading to altered transcription factor activity and gene expression, which may include effects on ZBTB41 expression. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
Sulforaphane is known to affect epigenetic regulation and might modulate the expression of a range of genes, including ZBTB41, by influencing histone modification and DNA methylation patterns. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a phytoestrogen, has been shown to affect gene expression by acting as a kinase inhibitor and through epigenetic mechanisms, which could potentially influence ZBTB41 expression. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram is known to inhibit nuclear factor kappa B (NF-κB) and may influence the expression of various genes regulated by this transcription factor, potentially including ZBTB41. | ||||||
Caffeic acid phenethyl ester | 104594-70-9 | sc-200800 sc-200800A sc-200800B | 20 mg 100 mg 1 g | $71.00 $296.00 $612.00 | 19 | |
CAPE is an active component of propolis with known modulatory effects on NF-κB, which might affect the expression of genes that are under the control of this transcription factor, possibly ZBTB41. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Parthenolide has been shown to inhibit NF-κB, which could lead to modulation of gene expression profiles, including the potential upregulation of ZBTB41. | ||||||
Dimethyloxaloylglycine (DMOG) | 89464-63-1 | sc-200755 sc-200755A sc-200755B sc-200755C | 10 mg 50 mg 100 mg 500 mg | $84.00 $301.00 $374.00 $779.00 | 25 | |
DMOG is an inhibitor of prolyl hydroxylases, leading to stabilization of hypoxia-inducible factors (HIFs), which may alter gene expression patterns, including the potential induction of ZBTB41 expression under hypoxic conditions. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A is known to bind to GC-rich sequences in DNA, potentially affecting the transcription of certain genes, which might include ZBTB41. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine is an inhibitor of DNA methyltransferases, leading to DNA demethylation and potentially resulting in the activation of gene expression, which could affect ZBTB41. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat is a histone deacetylase inhibitor, which could lead to chromatin remodeling and the subsequent activation of gene expression, potentially involving ZBTB41. | ||||||